Ship Validated Systems That Move Your Business Forward
The full validation package — risk assessment, test cases, live traceability — drafted from your own URS, with human review at every gate.
- GxP Validation
- AI Validation
- Clinical Documentation
- Regulatory Compliance
- Agentic AI Systems
See it working
Real screenshots from GxP Copilot — the validation portfolio dashboard, built-in document engine, tamper-evident audit trail, and AI assistant that knows your regulatory context.
GxP Copilot validation portfolio — live inspection readiness, AI assistant, and systems tracked at a glance.
Built-in document engine — draft, review, approve and sign the full deliverable lifecycle.
Tamper-evident audit trail — hash-chained, inspection-ready.
Ask GxP — AI assistant with regulatory context built in.
Getting Validated Shouldn't Feel
Like A Guessing Game
Without the right operating model, shipping compliant systems and regulator-ready documents is slow, expensive and uncertain. Too often, Life Sciences teams face:
Stop Guessing. Ship Validated.
Two AI-native platforms, purpose-built for regulated Life Sciences. Not workflow software with a chatbot bolted on.
Ship inspection-ready GxP systems in a fraction of the time — with the full validation package drafted for you, risk sized to reality, and Part 11 posture baked in from day one.
- Faster time-to-validated. A full GAMP 5 validation package drafted in days, not quarters — freeing your team to focus on judgment calls, not document assembly.
- CSA-first, not CSA-flavoured. Test rigor scales to real per-requirement risk under FDA CSA, so you spend effort where it changes the outcome and defensibly reduce it everywhere else.
- Inspection-ready by design. Tamper-evident audit trail, real Part 11 electronic signatures, and live traceability — the posture regulators expect, without a remediation project.
Turn writer capacity into a strategic advantage — AI-assisted clinical documents where every sentence traces back to the source data, with the compliance evidence attached on export.
- Every claim traces to source. Not summaries, not vibes — a defensible link from every sentence back to the underlying AE listing row, dataset value or protocol clause.
- Real 21 CFR Part 11 posture. Tamper-evident audit trail and real electronic signatures, so AI-assisted writing meets the same regulatory bar as human writing.
- Bring your own AI. The AI provider is swappable. Start today; move to a preferred model tomorrow — without touching your workflows or SOPs.
Solutions Built Around Your Operating Model
Five practice areas, delivered by leads who have shipped inspection-ready systems in FDA, EMA, MHRA, PMDA and CDSCO environments.
End-to-end computer system validation done the CSA way — risk-based, least-burdensome, AI-accelerated where it helps and human-owned where it must be. From URS to VSR, from IQ to periodic review, delivered by validation leads who have shipped inspection-ready systems in FDA, EMA, MHRA, PMDA and CDSCO regulated environments.
Learn more about Validation & Compliance ServicesClinical documentation and operations delivered by medical writers, biostatisticians and clinical operations leads — accelerated with TraceDraft where every AI-drafted sentence links back to the source data behind it.
Learn more about Clinical ServicesRegulatory operations, intelligence and technology — including implementation and validation of eQMS, RIM, LMS, DMS platforms, and CAPA / PV programme design.
Learn more about Regulatory ServicesAI transformation designed for regulated life sciences: strategy, governance, adoption, agentic systems and AI Centres of Excellence — validated where it needs to be, fast where it can be.
Learn more about AI TransformationOngoing managed services that own the outcome, not just the effort — with SLAs, dashboards, and a single accountable partner across validation, clinical, regulatory and AI operations.
Learn more about Managed ServicesCommon Challenges We Solve
Slow validation cycles, documentation bottlenecks, stale traceability and stalled AI adoption all limit how fast a Life Sciences business can move.
Legacy CSV practice defaults every requirement to scripted testing, inflating effort and delaying every go-live.
CSR, protocol and safety-narrative throughput is limited by writer headcount, not by data availability.
Teams have GenAI pilots they cannot promote to production because Annex 22 / Part 11 posture is undefined.
Static RTM spreadsheets can't answer coverage-gap or inspection-readiness questions on demand.
Client Success Stories
We had no dedicated QA function and could not absorb a twelve-month incumbent rollout. Cybroscape delivered a complete validation package for our LIMS deployment inside a month, and we were Part 11 posture at go-live.
Writer capacity was our ceiling on CSR turnaround. TraceDraft changed the constraint — and the provenance trail meant our sponsors were comfortable with AI-assisted authoring from the first study.
Inspection-Ready, Tailored To Your Estate
We design validation and clinical documentation systems that fit the estate you actually run — SAP, LIMS, MES, SCADA, eQMS, RIM — and the regulators you actually answer to. Our solutions scale test rigor to real risk, so you spend effort where it changes the outcome and nowhere else.
Why Choose Us?
We take the complexity out of GxP validation, compliance and clinical documentation, helping Life Sciences teams build systems that hold up under inspection.
Our leads have shipped inspection-ready validation packages and clinical documentation platforms across FDA, EMA, MHRA, PMDA and CDSCO regulated environments — pharma, biotech, med-device, CRO and diagnostics.
Real 21 CFR Part 11 electronic signatures with re-authentication, tamper-evident audit trails, enforced segregation of duties, and EU Annex 11 / Annex 22 posture included by design — not bolted on later.
You get the AI platform and the team that runs it. No vendor-to-consultant hand-off, no finger-pointing. From first assessment through managed operations, one accountable partner.
Built For Regulated Life Sciences
Every industry we serve carries its own regulations, its own risk topology, its own decision-makers. We speak all of them.
GMP, GDP, GxP validated systems for pharma manufacturing, quality & clinical
Learn more about GxP validation for PharmaceuticalsSeries A–C biotech: inspection posture without incumbent price tag
Learn more about GxP validation for BiotechnologyMDR / IVDR / QSR — validated systems, traceable CERs
Learn more about GxP validation for Medical DevicesClinical writing throughput without adding headcount
Learn more about GxP validation for Contract Research Organisations (CRO)IVD, LDT, molecular — validated LIMS, traceable performance evidence
Learn more about GxP validation for DiagnosticsDigital-health, HealthTech, SaMD — regulated velocity
Learn more about GxP validation for Healthcare TechnologyShip Validated Systems
Without The Guesswork
From first conversation to inspection-ready output, the path is short and the evidence is attached at every step.
Share your system, your URS, or an AE listing — and the outcome you need.
We run GxP Copilot or TraceDraft against your inputs, live, in 30 minutes.
Validation package or clinical document, with the evidence pack attached.
The Category We're Building: AI GxP
Legacy validation vendors built workflow tools. We're building the AI layer for validation, compliance and clinical documentation — with the assurance stack Annex 22 demands.
AI applied to GxP-regulated processes, validated per Annex 22.
GxP-native AI products — copilots, agents, classifiers — architected for regulated use.
Plan → retrieve → draft → critique → revise, with deterministic guardrails at every step.
AI drafts, humans decide. Quorum, segregation of duties, e-signature.
Every sentence traced to source data, via a provenance DAG.
CSV where the AI participates in evidence assembly — not just formatting.
Model card, eval set, drift, HITL, fallback — Annex 22-aligned.
AI for regulatory intelligence, RIM and PV — with assurance built in.
GxP & AI Validation FAQs
Got questions? We've got answers. Explore our most commonly asked questions to find exactly what you're looking for — quick, clear, and hassle-free.
What does Cybroscape Technologies do?+
Cybroscape is an AI-first Life Sciences Validation, Regulatory Compliance and Clinical Technology company. We build AI products — GxP Copilot for validation, TraceDraft for clinical documentation — and deliver services across CSV, CSA, AI validation, medical writing, regulatory operations and AI transformation for pharma, biotech, medical device, CRO, diagnostics and healthcare-technology operators.
How is Cybroscape different from legacy validation vendors?+
Legacy validation suites are configuration-heavy workflow tools with long implementation cycles, priced for large enterprises with a dedicated validation function. Cybroscape is AI-native and CSA-first: the full validation package is drafted for you, effort is sized to real per-requirement risk, and the compliance posture regulators expect is included by design — reachable in weeks rather than quarters, and priced for the mid-market segment incumbents overlook.
Is GxP Copilot 21 CFR Part 11 compliant?+
Yes. Electronic signatures include the ceremony 21 CFR Part 11 demands — including re-authentication at signing, meaning, name, timestamp and content binding. Authors cannot approve their own drafts. The audit trail is tamper-evident with an integrity check, and signed versions cannot be silently edited.
What is TraceDraft?+
TraceDraft is our AI clinical documentation platform. It drafts Clinical Study Reports, protocols and amendments, Investigator Brochures, DSURs, IND annual reports, HAQ responses, IND packages, safety narratives and Clinical Evaluation Reports — with every sentence linked back to the source data behind it, a dedicated human review queue, and a tamper-evident audit trail.
Do you serve companies outside pharma?+
Yes — we serve pharma, biotech, medical devices, CROs, diagnostics, vaccines, life sciences at large, and healthcare technology (SaMD and digital health).
How do you handle AI validation for GxP systems?+
Under EU Annex 22 (AI in GMP) and FDA's evolving AI/ML guidance. We validate AI systems the way GxP demands: published model governance, an evaluation set that gates every release, safeguards on AI outputs, a human-in-the-loop policy, drift monitoring, and a documented fallback so the workflow keeps running with the AI switched off.
Recent Blog Posts
Validation debt is the gap between what your documentation says a system is and what it actually is. Where it comes from, what it costs, and how to pay it down without a remediation project.
Read more: Validation Debt: The Cost You Are Already CarryingValidation projects rarely overrun because the regulatory thinking was hard. Five recurring causes, ranked by how much time they actually cost and how fixable each one is.
Read more: Why Validation Projects Overrun — and Which Causes Are Actually FixableAudit readiness is a retrieval problem before it is a documentation problem. A simple unannounced drill that tells you the truth about your estate in fifteen minutes.
Read more: The Retrieval Drill: A 15-Minute Test of Whether You Are Actually Audit ReadyUnlock Your Validation Potential And Start Shipping Faster
Bring a system, a URS, or an AE listing. We'll show you how GxP Copilot and TraceDraft compress the cycle without compromising Part 11 or Annex 22 posture.